Funding for this research was provided by:
Division of Pediatric Endocrinology Fellowship Research Funds at Children’s Mercy Kansas City
Received: 12 February 2023
Accepted: 21 August 2023
First Online: 19 September 2023
: MAC reports unrelated consulting fees from Glooko, as well as research support from Dexcom and Abbott Diabetes Care. The other authors have no potential conflicts of interest relevant to this study.
: The research related to human use has complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration. This study was originally planned to be accompanied by a survey, however, due to low response rate it was not analyzed. The retrospective chart review with de-identified data was analyzed and the need for informed consent was waived by the Institutional Review Board of Children’s Mercy Kansas City (Study00001810). This study was approved by the Institutional Review Board of Children’s Mercy Kansas City.
: Not applicable.